GPT and laryngotracheoesophageal cleft: A strategy for preventing HCC development other than IFN therapy is, therefore, urgently needed for those patients.We reported that the recurrence rate and the development of HCC was more rapid in the high serum ALT level (>80 IU) patients with HCV-associated LC.